LIAN BRIAN (President & CEO) sold 4.7% of their position (115.86K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.67M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+41K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
+163.33K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−65.94K
Price / share
$56.95
Trade value
$3.76M
% of position
Common Stock, par value $0.00001 per share
Shares
−19.50K
Price / share
$57.81
Trade value
$1.13M
% of position
Common Stock, par value $0.00001 per share
Shares
−30.42K
Price / share
$58.78
Trade value
$1.79M
% of position
Net shares
+88.47K
Net value
-$6.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 7/29/2024 | A · Award | +41K | — | — | 1.8% | 2.27M | 2.31M |
| Common Stock, par value $0.00001 per share Direct | 7/29/2024 | A · Award | +163.33K | — | — | 7.1% | 2.31M | 2.47M |
| Common Stock, par value $0.00001 per share Direct | 7/30/2024 | S · Sale | −65.94K | $56.95 | $3.76M | 2.7% | 2.47M | 2.40M |
| Common Stock, par value $0.00001 per share Direct | 7/30/2024 | S · Sale | −19.50K | $57.81 | $1.13M | 0.8% | 2.40M | 2.39M |
| Common Stock, par value $0.00001 per share Direct | 7/30/2024 | S · Sale | −30.42K | $58.78 | $1.79M | 1.3% | 2.39M | 2.35M |
| Total | +88.47K | -$6.67M | ||||||